MAPK Signaling
Activated MAPKs transduce the phosphorylation and activation of MAPK-activated protein kinases (MAPKAPKs), e.g. RSK, MSK, or MNK family, and MK2/3/5. There are three main MAPK families, signal-regulated kinase 1 and 2 (Erk1/2 or p44/42), the c-Jun N-terminal kinases 1-3 (JNK1-3)/ stress activated protein kinases (SAPK1A, 1B, 1C), the p38 isoforms (p38α, β, γ, and δ). ERK signaling is involved in cell division, migration and survival. p38 MAPK and JNK/SAPK pathways are activated by cellular stress. The p38 MAPK pathway regulates cell motility, transcription, and chromatin remodeling. JNK/SAPK signaling affects apoptosis and inflammation. Dysregulation of MAPK pathway results in tumorgenesis and other pathological conditions.
- B1621 TAK-733Target: MEKSummary: MEK allosteric site inhibitor
- B7784 AL 8697Target: p38Summary: p38α inhibitor,potent and selective
- A8716 LY3009120Target: RafSummary: pan-RAF and RAF dimer inhibitor
- B6012 Pexmetinib (ARRY-614)Target: p38|Tie-2Summary: dual inhibitor of p38 MAPK and Tie2/Tek receptor tyrosine kinase
- B1407 Dabrafenib (GSK2118436)3 CitationTarget: RafSummary: Inhibitor of BRAF(V600) mutants
- B1267 RefametinibTarget: MEKSummary: MEK 1/ MEK 2 inhibitor
- B1174 LGX818Target: RafSummary: RAF inhibitor,potent and selective
- B1135 GDC-0623Target: MEKSummary: MEK1 inhibitor, potent and ATP-uncompetitive
- B5549 PF-3644022Target: MK2Summary: Potent and Selective MK2 inhibitor
- B7321 TCS JNK 6oTarget: JNKSummary: JNK inhibitor